Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
28.61
+2.61 (10.04%)
At close: Dec 9, 2025
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees
35,686
Change (1Y)
-786
Growth (1Y)
-2.16%
Revenue / Employee
$482,221
Profits / Employee
$20,495
Market Cap
36.41B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35,686 | -786 | -2.16% |
| Dec 31, 2023 | 36,472 | 1,347 | 3.83% |
| Dec 31, 2022 | 35,125 | -854 | -2.37% |
| Dec 31, 2021 | 35,979 | -2,393 | -6.24% |
| Dec 31, 2020 | 38,372 | -1,667 | -4.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
Teva Pharmaceutical Industries News
- 1 day ago - Teva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade) - Seeking Alpha
- 3 days ago - Piper Sandler Elevates TEVA Price Target to $40 with Overweight Rating | TEVA Stock News - GuruFocus
- 5 days ago - Goldman Sachs Raises TEVA Price Target to $35, Maintains Buy Rating | TEVA Stock News - GuruFocus
- 6 days ago - Insider Selling: Amir Weiss Unloads $371K Of Teva Pharmaceutical Indus Stock - Benzinga
- 6 days ago - Alvotech, Teva Secures U.S. License Entry Date For Eylea Biosimilar AVT06 - Nasdaq
- 6 days ago - Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S. - Seeking Alpha
- 6 days ago - Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea® - GlobeNewsWire
- 6 days ago - My Top 10 Portfolio Holdings for 2026 - The Motley Fool